Click to deselect and select. Feb 12, 2026, 10:13 PM IST Syncom Formul. - Regulation 33(3) Of SEBI (LODR) Regulations, 2015 - Submission Of Standalone & Consolidated Unaudited Financ Feb 04, 2026, ...

Syncom Formulations India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2015, to consider and approve the followings:1. Audited Financial Results ...

Syncom Formulations India has a price-to-earnings (P/E) ratio of 22.59 (TTM). This compares to an industry average of 37.81. What is Syncom Formulations India’s price-to-sales ratio? The P/S ratio for ...

Syncom Formulations India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 22, 2013, for making allotment of 55,76,08,700 (Fifty Five Crores Seventy ...

Syncom Formulations India declared their Q3 FY24 results on 14 Feb, 2024. The topline increased by 13.52% & the profit increased by 68.92% YoY. As compared to the previous quarter, the revenue grew by ...

Explore the BO:SYFI financials. Find the Syncom Formulations India financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from ...

Oct 16, 2025, 11:49 PM IST Syncom Formul. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Oct 01, 2025, 11:39 PM IST Syncom Formul. - Announcement under Regulation 30 (LODR) ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The Syncom Formulations India Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹15.87 today. What is the Market Cap of Syncom Formulations India Ltd? Market capitalization, short for market cap, ...

View all information regarding the medicines that are manufactured by Syncom Formulations I Ltd. including its generic drug name, trade name, how to use, the price, and its composition.

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health ...

Syncom Formulations India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 11, 2011, inter alia, to consider the following businesses: 1. To consider ...